Therapeutic effect of a T helper cell supported CTL response induced by a survivin peptide vaccine against murine cerebral glioma

Cancer Immunology, Immunotherapy

Volumn 57, Issue 12, 2008, Pages 1827-1835

  Ciesielski, Michael J ^a   Kozbor, Danuta ^a   Castanaro, Carla A ^a   Barone, Tara A ^a   Fenstermaker, Robert A ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Dendritic cell; Glioma; Peptide; Survivin; Tumor antigen; Vaccine

Indexed keywords

DENDRITIC CELL VACCINE; EPITOPE; PEPTIDE VACCINE; SURVIVIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FLOW CYTOMETRY; GLIOMA; HELPER CELL; IMMUNE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; SPLEEN CELL;

ANIMALS; BRAIN NEOPLASMS; CANCER VACCINES; DENDRITIC CELLS; EPITOPES, T-LYMPHOCYTE; FLOW CYTOMETRY; GLIOMA; HISTOCOMPATIBILITY ANTIGENS; MALE; MICE; MICE, INBRED C57BL; MICROTUBULE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, HELPER-INDUCER; VACCINES, SUBUNIT;

EID: 52549097557     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00262-008-0510-9     Document Type: Article

References (30)

1. A Giese M Westphal 2001 Treatment of malignant glioma: a problem beyond the margins of resection J Cancer Res Clin Oncol 127 217 225
2. EC Halperin PC Burger DE Bullard 1988 The fallacy of the localized supratentorial malignant glioma Int J Radiat Oncol Biol Phys 15 505 509
3. R Stupp WP Mason MJ van den Bent 2005 Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma N Engl J Med 10 987 996
4. DC Altieri 2003 Validating survivin as a cancer therapeutic target Nat Rev Cancer 3 46 54
5. C Adida PL Crotty J McGrath 1998 Developmentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation Am J Pathol 152 43 49
6. Y Kajiwara F Yamasaki S Hama 2003 Expression of survivin in astrocytic tumors Cancer 97 1077 1083
7. T Sasaki MB Lopes GR Hankins GA Helm 2002 Expression of survivin an inhibitor of apoptosis protein in tumors of the nervous system Acta Neuropathol (Berl) 104 105 109
8. A Chakravarti E Noll P Black 2002 Quantitatively determined survivin expression levels are of prognostic value in human gliomas J Clin Oncol 20 1063 1068
9. A Islam H Kageyama N Takada 2000 A high expression of survivin mapped to 17q25 is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma Oncogene 19 617 23
10. MH Andersen LO Pedersen B Capeller 2001 Spontaneous cytotoxic T-cell responses against survivin-derived MHC class I-restricted T-cell epitopes in situ as well as ex vivo in cancer patients Cancer Res 61 5964 5968
11. RA Fenstermaker MJ Ciesielski 2004 Immunotherapeutic strategies for malignant gliomas Cancer Control 11 181 191
12. MJ Ciesielski L Apfel TA Barone CA Castro TC Weiss RA Fenstermaker 2006 Antitumor effects of a xenogeneic survivin bone marrow derived dendritic cell vaccine against murine GL261 gliomas Cancer Immunol Immunother 55 1491 1503
13. HG Rammensee J Bachmann NN Emmerich OA Bachor S Stevanovic 1999 SYFPEITHI: database for MHC ligands and peptide motifs Immunogenetics 50 213 219
14. D Kmieciak I Bednarek M Takiguchi TJ Wasik J Bratosiewicz A Wierzbicki H Teppler J Pientka SH Hsu Y Kaneko D Kozbor 1998 The effect of epitope variation on the profile of cytotoxic T lymphocyte responses to the HIV envelope glycoprotein Int Immunol 10 1789 99
15. JD Gordan RH Vonderheide 2002 Universal tumor antigens as targets for immunotherapy Cytotherapy 4 317 27
16. DC Altieri 2003 Survivin and apoptosis control Adv Cancer Res 88 31 52
17. DC Altieri 2001 The molecular basis and potential role of survivin in cancer diagnosis and therapy Trends Mol Med 7 542 7
18. MH Andersen LO Pedersen JC Becker P Straten 2001 Identification of a cytotoxic T lymphocyte response to the apoptosis inhibitor protein survivin in cancer patients Cancer Res 61 869 72
19. M Schmitz P Diestelkoetter B Weigle 2000 Generation of survivin-specific CD8+ T effector cells by dendritic cells pulsed with protein or selected peptides Cancer Res 60 4845 9
20. LM Liau KL Black NA Martin 2000 Treatment of a glioblastoma patient by vaccination with autologous dendritic cells pulsed with allogeneic major histocompatibility complex class I-matched tumor peptides Neurosurg Focus 9 e8
21. JS Yu CJ Wheeler PM Zeltzer 2001 Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration Cancer Res 61 842 7
22. JS Yu G Liu H Ying 2004 Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific cytotoxic T-cells in patients with malignant glioma Cancer Res 64 4973 9
23. T Kikuchi Y Akasaki M Irie 2001 Results of a phase I clinical trial of vaccination of glioma patients with fusions of dendritic and glioma cells Cancer Immunol Immunother 50 337 44
24. M Zeis S Siegel A Wagner 2003 A Generation of cytotoxic responses in mice and human individually against hematological malignancies using survivin-RNA-transfected dendritic cells J Immunol 170 5391 7
25. R Xiang N Mizutani Y Luo 2005 A DNA vaccine targeting survivin combines apoptosis with suppression of angiogenesis in lung tumor eradication Cancer Res 65 553 561
26. K Zhu H Qin SC Cha SS Neelapu W Overwijk GA Lizee JL Abbruzzese P Hwu L Radvanyi LW Kwak DZ Chang 2007 Survivin DNA vaccine generated specific antitumor effects in pancreatic carcinoma and lymphoma mouse models Vaccine 25 7955 61
27. S Nagaraj V Pisarev L Kinarsky S Sherman C Muro-Cacho DC Altieri DI Gabrilovich 2007 Dendritic cell-based full-length survivin vaccine in treatment of experimental tumors J Immunother 30 169 79
28. Z Yang L Wang H Wang X Shang W Niu J Li Y Wu 2008 A novel mimovirus vaccine containing survivin epitope with adjuvant IL-15 induces long-lasting cellular immunity and high antitumor efficiency Mol Immunol 45 1674 1681
29. M Piesche Y Hildebrandt F Zettl B Chapuy M Schmitz G Wulf L Trümper R Schroers 2007 Identification of a promiscuous HLA DR-restricted T-cell epitope derived from the inhibitor of apoptosis protein survivin Hum Immunol 68 572 6
30. A Charalambous M Oks G Nchinda S Yamazaki RM Steinman 2006 Dendritic cell targeting of survivin protein in a xenogeneic form elicits strong CD4+ T cell immunity to mouse survivin J Immunol 177 8410 21